(Q44765714)

English

The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study

scientific article published in March 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

systolic hypertension

1 reference

based on heuristic

inferred from title

8

object named as

Ulf de Faire

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

4

object named as

Björn Dahlöf

0 references

Ole Lederballe-Pedersen

12

object named as

Ole Lederballe-Pedersen

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sverre E. Kjeldsen

1

object named as

Sverre E Kjeldsen

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Richard B Devereux

5

object named as

Richard B Devereux

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

16

object named as

Suzanne Oparil

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Paulette A Lyle

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Jorge R Kizer

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Stevo Julius

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Gareth Beevers

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Frej Fyhrquist

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Hans Ibsen

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Krister Kristianson

11

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Lars H Lindholm

13

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Markku S Nieminen

14

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Per Omvik

15

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Steven M Snapinn

17

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Katherine E Harris

18

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Hans Wedel

19

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

LIFE Study Group

20

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

152-158

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Mortality by cause for eight regions of the world: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Blood pressure and stroke: an overview of published reviews

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Prognostic significance of left ventricular mass change during treatment of hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Effect of angiotensin ii receptor blockade on arterial stiffness: beyond blood pressure reduction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Protection against ischemia: a physiological function of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Blood-pressure reduction and cardiovascular risk in HOPE study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

The impact of serum uric acid on cardiovascular outcomes in the LIFE study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Population impact of losartan use on stroke in the European Union (EU): projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Secular trends in stroke incidence and mortality. The Framingham Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04254.X

21 January 2018

Identifiers

10.1111/J.1524-6175.2005.04254.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44765714&oldid=2061776506"